Phenytoin and cognitive decline.
Koch
Sebastian
S
Gidal
Barry E
BE
D000927:Anticonvulsants / Q000009:adverse effects; D019540:Area Under Curve; D002121:Calcium Channel Blockers / Q000009:adverse effects; D003072:Cognition Disorders / Q000139:chemically induced* / Q000503:physiopathology; D003577:Cytochrome P-450 Enzyme System / Q000737:chemistry; D006801:Humans; D009553:Nimodipine / Q000009:adverse effects / Q000493:pharmacokinetics; D010672:Phenytoin / Q000009:adverse effects*; D012640:Seizures / Q000209:etiology / Q000517:prevention & control; D013997:Time Factors; D016896:Treatment Outcome
D000927:Anticonvulsants; D002121:Calcium Channel Blockers; D009553:Nimodipine; D010672:Phenytoin; D003577:Cytochrome P-450 Enzyme System